Peritoneal Carcinomatosis from Colon Cancer: A Systematic Review of the Data for Cytoreduction and Intraperitoneal Chemotherapy

 

 Buy Article Permissions and Reprints

Abstract

A systematic review of the literature on the management of peritoneal carcinomatosis (PC) from colon cancer with cytoreductive surgery (CRS) and intraperitoneal chemotherapy (IPC) was undertaken using OVID Medline. Forty-six relevant studies were reviewed. Mean weighted overall morbidity following CRS and IPC was 49% (range 22–76%) and mortality was 3.6% (range 0–19%). Median overall survival ranged from 15 to 63 months, and 5-year overall survival ranged from 7 to 100%. This represents an improvement over historical treatment with systemic chemotherapy alone, even in the era of modern chemotherapeutic agents. Quality of life following surgery is initially decreased but improves with time and approaches baseline. Available data appear to support the treatment of PC from colon cancer with CRS and IPC. There is a large amount of variability among studies and few high-quality studies exist. Further studies are needed to standardize techniques.

• References

• 1 Jayne DG, Fook S, Loi C, Seow-Choen F. Peritoneal carcinomatosis from colorectal cancer. Br J Surg 2002; 89 (12) 1545-1550
  CrossrefPubMedGoogle Scholar
• 2 Glehen O, Osinsky D, Beaujard AC, Gilly FN. Natural history of peritoneal carcinomatosis from nongynecologic malignancies. Surg Oncol Clin N Am 2003; 12 (3) 729-739 , xiii
  CrossrefPubMedGoogle Scholar
• 3 Sugarbaker PH, Cunliffe WJ, Belliveau J , et al. Rationale for integrating early postoperative intraperitoneal chemotherapy into the surgical treatment of gastrointestinal cancer. Semin Oncol 1989; 16 (4) (Suppl. 06) 83-97
  PubMedGoogle Scholar
• 4 Minsky BD, Mies C, Rich TA, Recht A, Chaffey JT. Potentially curative surgery of colon cancer: patterns of failure and survival. J Clin Oncol 1988; 6 (1) 106-118
  PubMedGoogle Scholar
• 5 Verwaal VJ, van Ruth S, de Bree E , et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 2003; 21 (20) 3737-3743
  CrossrefPubMedGoogle Scholar
• 6 Meyerhardt JA, Mayer RJ. Systemic therapy for colorectal cancer. N Engl J Med 2005; 352 (5) 476-487
  CrossrefPubMedGoogle Scholar
• 7 Elias D, Lefevre JH, Chevalier J , et al. Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. J Clin Oncol 2009; 27 (5) 681-685
  CrossrefPubMedGoogle Scholar
• 8 Franko J, Ibrahim Z, Gusani NJ, Holtzman MP, Bartlett DL, Zeh III HJ. Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for colorectal peritoneal carcinomatosis. Cancer 2010; 116 (16) 3756-3762
  CrossrefPubMedGoogle Scholar
• 9 Tomlinson JS, Jarnagin WR, DeMatteo RP , et al. Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol 2007; 25 (29) 4575-4580
  CrossrefPubMedGoogle Scholar
• 10 Sugarbaker PH. Strategies for the prevention and treatment of peritoneal carcinomatosis from gastrointestinal cancer. Cancer Invest 2005; 23 (2) 155-172
  CrossrefPubMedGoogle Scholar
• 11 de Bree E, Koops W, Kröger R, van Ruth S, Verwaal VJ, Zoetmulder FAN. Preoperative computed tomography and selection of patients with colorectal peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Eur J Surg Oncol 2006; 32 (1) 65-71
  CrossrefPubMedGoogle Scholar
• 12 Harmon RL, Sugarbaker PH. Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer. Int Semin Surg Oncol 2005; 2 (1) 3
  CrossrefPubMedGoogle Scholar
• 13 Phillips B, Ball C, Sackett D , et al. Oxford Centre for Evidence-Based Medicine Levels of Evidence (March 2009); 2009 . Available at: http://www.cebm.net/ . Accessed on February 2014
  PubMed
• 14 Cashin PH, Graf W, Nygren P, Mahteme H. Cytoreductive surgery and intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis: prognosis and treatment of recurrences in a cohort study. Eur J Surg Oncol 2012; 38 (6) 509-515
  CrossrefPubMedGoogle Scholar
• 15 Elias D, Benizri E, Di Pietrantonio D, Menegon P, Malka D, Raynard B. Comparison of two kinds of intraperitoneal chemotherapy following complete cytoreductive surgery of colorectal peritoneal carcinomatosis. Ann Surg Oncol 2007; 14 (2) 509-514
  CrossrefPubMedGoogle Scholar
• 16 Shiu MH, Fortner JG. Intraperitoneal hyperthermic treatment of implanted peritoneal cancer in rats. Cancer Res 1980; 40 (11) 4081-4084
  PubMedGoogle Scholar
• 17 Los G, Smals OA, van Vugt MJ , et al. A rationale for carboplatin treatment and abdominal hyperthermia in cancers restricted to the peritoneal cavity. Cancer Res 1992; 52 (5) 1252-1258
  PubMedGoogle Scholar
• 18 Los G, van Vugt MJ, Pinedo HM. Response of peritoneal solid tumours after intraperitoneal chemohyperthermia treatment with cisplatin or carboplatin. Br J Cancer 1994; 69 (2) 235-241
  CrossrefPubMedGoogle Scholar
• 19 Quenet F, Goéré D, Mehta SS , et al. Results of two bi-institutional prospective studies using intraperitoneal oxaliplatin with or without irinotecan during HIPEC after cytoreductive surgery for colorectal carcinomatosis. Ann Surg 2011; 254 (2) 294-301
  CrossrefPubMedGoogle Scholar
• 20 McConnell YJ, Mack LA, Francis WP, Ho T, Temple WJ. HIPEC + EPIC versus HIPEC-alone: differences in major complications following cytoreduction surgery for peritoneal malignancy. J Surg Oncol 2013; 107 (6) 591-596
  CrossrefPubMedGoogle Scholar
• 21 Elias D, Delperro JR, Sideris L , et al. Treatment of peritoneal carcinomatosis from colorectal cancer: impact of complete cytoreductive surgery and difficulties in conducting randomized trials. Ann Surg Oncol 2004; 11 (5) 518-521
  CrossrefPubMedGoogle Scholar
• 22 Hill AR, McQuellon RP, Russell GB, Shen P, Stewart IV JH, Levine EA. Survival and quality of life following cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis of colonic origin. Ann Surg Oncol 2011; 18 (13) 3673-3679
  CrossrefPubMedGoogle Scholar
• 23 Tsilimparis N, Bockelmann C, Raue W , et al. Quality of life in patients after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: is it worth the risk?. Ann Surg Oncol 2013; 20 (1) 226-232
  CrossrefPubMedGoogle Scholar
• 24 McQuellon RP, Loggie BW, Fleming RA, Russell GB, Lehman AB, Rambo TD. Quality of life after intraperitoneal hyperthermic chemotherapy (IPHC) for peritoneal carcinomatosis. Eur J Surg Oncol 2001; 27 (1) 65-73
  CrossrefPubMedGoogle Scholar
• 25 Macrì A, Maugeri I, Trimarchi G , et al. Evaluation of quality of life of patients submitted to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinosis of gastrointestinal and ovarian origin and identification of factors influencing outcome. In Vivo 2009; 23 (1) 147-150
  PubMedGoogle Scholar
• 26 Kianmanesh R, Scaringi S, Sabate J-M , et al. Iterative cytoreductive surgery associated with hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis of colorectal origin with or without liver metastases. Ann Surg 2007; 245 (4) 597-603
  CrossrefPubMedGoogle Scholar
• 27 Chua TC, Yan TD, Zhao J, Morris DL. Peritoneal carcinomatosis and liver metastases from colorectal cancer treated with cytoreductive surgery perioperative intraperitoneal chemotherapy and liver resection. Eur J Surg Oncol 2009; 35 (12) 1299-1305
  CrossrefPubMedGoogle Scholar
• 28 Maggiori L, Goéré D, Viana B , et al. Should patients with peritoneal carcinomatosis of colorectal origin with synchronous liver metastases be treated with a curative intent? A case-control study. Ann Surg 2013; 258 (1) 116-121
  CrossrefPubMedGoogle Scholar
• 29 Stojadinovic A. Standard therapy with or without surgery and Mitomycin C in treating patients with advanced limited peritoneal dissemination of colon cancer. Clinical trial NCT01167725. Available at: http://clinicaltrials.gov/show/NCT01167725 . Accessed on February 2014
  PubMedGoogle Scholar
• 30 Graf W. Cytoreduction and intraperitoneal chemotherapy versus systemic chemotherapy in colorectal peritoneal carcinomatosis. Clinical trial NCT01524094. Available at: http://clinicaltrials.gov/show/NCT01524094 . Accessed on February 2014
  PubMedGoogle Scholar
• 31 Quenet F. Systemic chemotherapy with or without intraperitoneal chemohyperthermia in treating patients undergoing surgery for peritoneal carcinomatosis from colorectal cancer. Clinical trial NCT00769405. Available at: http://clinicaltrials.gov/ct2/show/NCT00769405 . Accessed on February 2014
  PubMedGoogle Scholar
• 32 Nash G. ICARuS post-operative intraperitoneal chemotherapy (EPIC) and hyperthermic intraperitoneal chemotherapy (HIPEC) after optimal cytoreductive surgery (CRS) for neoplasms of the appendix, colon or rectum with isolated peritoneal metastasis. Clinical trial NCT01815359. Available at: http://clinicaltrials.gov/ct2/show/NCT01815359 . Accessed on February 2014
  PubMedGoogle Scholar
• 33 Pestieau SR, Sugarbaker PH. Treatment of primary colon cancer with peritoneal carcinomatosis: comparison of concomitant vs. delayed management. Dis Colon Rectum 2000; 43 (10) 1341-1346 , discussion 1347–1348
  CrossrefPubMedGoogle Scholar
• 34 Elias D, Blot F, El Otmany A , et al. Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. Cancer 2001; 92 (1) 71-76
  CrossrefPubMedGoogle Scholar
• 35 Pilati P, Mocellin S, Rossi CR , et al. Cytoreductive surgery combined with hyperthermic intraperitoneal intraoperative chemotherapy for peritoneal carcinomatosis arising from colon adenocarcinoma. Ann Surg Oncol 2003; 10 (5) 508-513
  CrossrefPubMedGoogle Scholar
• 36 Glehen O, Cotte E, Schreiber V, Sayag-Beaujard AC, Vignal J, Gilly FN. Intraperitoneal chemohyperthermia and attempted cytoreductive surgery in patients with peritoneal carcinomatosis of colorectal origin. Br J Surg 2004; 91 (6) 747-754
  CrossrefPubMedGoogle Scholar
• 37 Glehen O, Kwiatkowski F, Sugarbaker PH , et al. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol 2004; 22 (16) 3284-3292
  CrossrefPubMedGoogle Scholar
• 38 Shen P, Hawksworth J, Lovato J , et al. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy with mitomycin C for peritoneal carcinomatosis from nonappendiceal colorectal carcinoma. Ann Surg Oncol 2004; 11 (2) 178-186
  CrossrefPubMedGoogle Scholar
• 39 Verwaal VJ, van Tinteren H, van Ruth S, Zoetmulder FA. Predicting the survival of patients with peritoneal carcinomatosis of colorectal origin treated by aggressive cytoreduction and hyperthermic intraperitoneal chemotherapy. Br J Surg 2004; 91 (6) 739-746
  CrossrefPubMedGoogle Scholar
• 40 Kecmanovic DM, Pavlov MJ, Ceranic MS, Sepetkovski AV, Kovacevic PA, Stamenkovic AB. Treatment of peritoneal carcinomatosis from colorectal cancer by cytoreductive surgery and hyperthermic perioperative intraperitoneal chemotherapy. Eur J Surg Oncol 2005; 31 (2) 147-152
  CrossrefPubMedGoogle Scholar
• 41 Verwaal VJ, van Ruth S, Witkamp A, Boot H, van Slooten G, Zoetmulder FA. Long-term survival of peritoneal carcinomatosis of colorectal origin. Ann Surg Oncol 2005; 12 (1) 65-71
  CrossrefPubMedGoogle Scholar
• 42 Cavaliere F, Valle M, De Simone M , et al. 120 peritoneal carcinomatoses from colorectal cancer treated with peritonectomy and intra-abdominal chemohyperthermia: a S.I.T.I.L.O. multicentric study. In Vivo 2006; 20 (6A): 747-750
  PubMedGoogle Scholar
• 43 da Silva RG, Sugarbaker PH. Analysis of prognostic factors in seventy patients having a complete cytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancer. J Am Coll Surg 2006; 203 (6) 878-886
  CrossrefPubMedGoogle Scholar
• 44 Füzün M, Sökmen S, Terzi C, Canda AE. Cytoreductive approach to peritoneal carcinomatosis originated from colorectal cancer: Turkish experience. Acta Chir Iugosl 2006; 53 (2) 17-21
  PubMedGoogle Scholar
• 45 Zanon C, Bortolini M, Chiappino I , et al. Cytoreductive surgery combined with intraperitoneal chemohyperthermia for the treatment of advanced colon cancer. World J Surg 2006; 30 (11) 2025-2032
  CrossrefPubMedGoogle Scholar
• 46 Bijelic L, Yan TD, Sugarbaker PH. Failure analysis of recurrent disease following complete cytoreduction and perioperative intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer. Ann Surg Oncol 2007; 14 (8) 2281-2288
  CrossrefPubMedGoogle Scholar
• 47 Piso P, Dahlke MH, Ghali N , et al. Multimodality treatment of peritoneal carcinomatosis from colorectal cancer: first results of a new German centre for peritoneal surface malignancies. Int J Colorectal Dis 2007; 22 (11) 1295-1300
  CrossrefPubMedGoogle Scholar
• 48 Franko J, Gusani NJ, Holtzman MP , et al. Multivisceral resection does not affect morbidity and survival after cytoreductive surgery and chemoperfusion for carcinomatosis from colorectal cancer. Ann Surg Oncol 2008; 15 (11) 3065-3072
  CrossrefPubMedGoogle Scholar
• 49 Verwaal VJ, Bruin S, Boot H, van Slooten G, van Tinteren H. 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol 2008; 15 (9) 2426-2432
  CrossrefPubMedGoogle Scholar
• 50 Yan TD, Morris DL. Cytoreductive surgery and perioperative intraperitoneal chemotherapy for isolated colorectal peritoneal carcinomatosis: experimental therapy or standard of care?. Ann Surg 2008; 248 (5) 829-835
  PubMedGoogle Scholar
• 51 Pelz JO, Stojadinovic A, Nissan A, Hohenberger W, Esquivel J. Evaluation of a peritoneal surface disease severity score in patients with colon cancer with peritoneal carcinomatosis. J Surg Oncol 2009; 99 (1) 9-15
  CrossrefPubMedGoogle Scholar
• 52 Swellengrebel HA, Zoetmulder FA, Smeenk RM, Antonini N, Verwaal VJ. Quantitative intra-operative assessment of peritoneal carcinomatosis—a comparison of three prognostic tools. Eur J Surg Oncol 2009; 35 (10) 1078-1084
  CrossrefPubMedGoogle Scholar
• 53 Bretcha-Boix P, Farré-Alegre J, Sureda M, Dussan C, Pérez Ruixo JJ, Brugarolas Masllorens A. Cytoreductive surgery and perioperative intraperitoneal chemotherapy in patients with peritoneal carcinomatosis of colonic origin: outcomes after 7 years' experience of a new centre for peritoneal surface malignancies. Clin Transl Oncol 2010; 12 (6) 437-442
  CrossrefPubMedGoogle Scholar
• 54 Chua TC, Morris DL, Esquivel J. Impact of the peritoneal surface disease severity score on survival in patients with colorectal cancer peritoneal carcinomatosis undergoing complete cytoreduction and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol 2010; 17 (5) 1330-1336
  CrossrefPubMedGoogle Scholar
• 55 Elias D, Gilly F, Boutitie F , et al. Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. J Clin Oncol 2010; 28 (1) 63-68
  CrossrefPubMedGoogle Scholar
• 56 Saxena A, Yan TD, Morris DL. A critical evaluation of risk factors for complications after cytoreductive surgery and perioperative intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis. World J Surg 2010; 34 (1) 70-78
  CrossrefPubMedGoogle Scholar
• 57 Vaira M, Cioppa T, D'Amico S , et al. Treatment of peritoneal carcinomatosis from colonic cancer by cytoreduction, peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC). Experience of ten years. In Vivo 2010; 24 (1) 79-84
  PubMedGoogle Scholar
• 58 Cavaliere F, De Simone M, Virzì S , et al. Prognostic factors and oncologic outcome in 146 patients with colorectal peritoneal carcinomatosis treated with cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy: Italian multicenter study S.I.T.I.L.O. Eur J Surg Oncol 2011; 37 (2) 148-154
  CrossrefPubMedGoogle Scholar
• 59 Chua TC, Morris DL, Saxena A , et al. Influence of modern systemic therapies as adjunct to cytoreduction and perioperative intraperitoneal chemotherapy for patients with colorectal peritoneal carcinomatosis: a multicenter study. Ann Surg Oncol 2011; 18 (6) 1560-1567
  CrossrefPubMedGoogle Scholar
• 60 Klaver YL, de Hingh IH, Boot H, Verwaal VJ. Results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy after early failure of adjuvant systemic chemotherapy. J Surg Oncol 2011; 103 (5) 431-434
  CrossrefPubMedGoogle Scholar
• 61 Stojadinovic A, Nissan A, Eberhardt J, Chua TC, Pelz JO, Esquivel J. Development of a Bayesian Belief Network Model for personalized prognostic risk assessment in colon carcinomatosis. Am Surg 2011; 77 (2) 221-230
  PubMedGoogle Scholar
• 62 Cashin PH, Graf W, Nygren P, Mahteme H. Intraoperative hyperthermic versus postoperative normothermic intraperitoneal chemotherapy for colonic peritoneal carcinomatosis: a case-control study. Ann Oncol 2012; 23 (3) 647-652
  CrossrefPubMedGoogle Scholar
• 63 Hompes D, D'Hoore A, Van Cutsem E , et al. The treatment of peritoneal carcinomatosis of colorectal cancer with complete cytoreductive surgery and hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) with oxaliplatin: a Belgian multicentre prospective phase II clinical study. Ann Surg Oncol 2012; 19 (7) 2186-2194
  CrossrefPubMedGoogle Scholar
• 64 Klaver YL, Chua TC, de Hingh IH, Morris DL. Outcomes of elderly patients undergoing cytoreductive surgery and perioperative intraperitoneal chemotherapy for colorectal cancer peritoneal carcinomatosis. J Surg Oncol 2012; 105 (2) 113-118
  CrossrefPubMedGoogle Scholar
• 65 Passot G, Vaudoyer D, Cotte E , et al. Progression following neoadjuvant systemic chemotherapy may not be a contraindication to a curative approach for colorectal carcinomatosis. Ann Surg 2012; 256 (1) 125-129
  CrossrefPubMedGoogle Scholar
• 66 Goéré D, Malka D, Tzanis D , et al. Is there a possibility of a cure in patients with colorectal peritoneal carcinomatosis amenable to complete cytoreductive surgery and intraperitoneal chemotherapy?. Ann Surg 2013; 257 (6) 1065-1071
  CrossrefPubMedGoogle Scholar
• 67 Yonemura Y, Canbay E, Ishibashi H. Prognostic factors of peritoneal metastases from colorectal cancer following cytoreductive surgery and perioperative chemotherapy. ScientificWorldJournal 2013; 2013: 978394
  PubMedGoogle Scholar